家庭輸液治療市場規模、佔有率、成長分析、按產品、按應用、按管理方法、按地區 - 按行業預測，2024-2031 年

Home Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Intravenous Sets), By Application (Anti Infective, Endocrinology, Hydration Therapy), By Administration, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月17日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球家庭輸液治療市場規模估值為354億美元，從2023年的385億美元成長到2031年的718億美元，預計在預測期內（2024-2031年）年複合成長率為8.1。％。

市場洞察表明，在患者成本降低和家庭護理需求激增的推動下，居家醫療（尤其是輸液治療）發生了重大轉變。由於疫情使醫院資源緊張，許多患者選擇居家醫療來繼續提供基本醫療服務。主要市場促進因素包括輸液設備的技術進步以及隨著患者尋求更方便的選擇而對家庭治療的日益偏好。 Option Care Health Inc. 等家庭輸液服務供應商與醫院和藥局合作，簡化患者接受治療的過程並制定個人化的治療計劃。此類合作刺激了對家庭輸液用品和服務的需求，特別是在新興市場，並改善了居家醫療解決方案的整體格局。

百特國際公司（美國）
費森尤斯卡比股份公司（德國）
梯瓦製藥工業股份有限公司（以色列）
麥克森公司（美國）
Option Care Health（美國）
美源伯根公司（美國）
CVS 健康（美國）
Walgreens Boots Alliance（USA/UK）
康德樂（美國）
林德公司（英國）
Centene 公司（美國）
聯合健康集團（美國）
Anthem, Inc.（美國）
Humana 公司（美國）
信諾公司（美國）
Koninklijke Philips NV（荷蘭）
史密斯醫療（英國）
ICU 醫療公司（美國）
泰爾茂株式會社（日本）
BD（美國）
結論與建議

簡介目錄

Product Code: SQSG35J2007

Global Home Infusion Therapy Market size was valued at USD 35.4 billion in 2022 and is poised to grow from USD 38.5 billion in 2023 to USD 71.8 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

Market insights indicate a significant shift towards home healthcare, particularly in infusion therapies, driven by reduced patient costs and a surge in demand for home-based treatments. With hospitals experiencing resource strain due to the pandemic, many patients opted for home care to continue essential medical services. Key market drivers include technological advancements in infusion devices and a growing preference for home treatments, as patients seek more convenient options. Home infusion service providers, such as Option Care Health Inc., are partnering with hospitals and pharmacies to streamline patient access to care and tailor personalized treatment plans. This collaboration has fueled the demand for home infusion supplies and services, especially in developed markets, enhancing the overall landscape of home healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Home Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Home Infusion Therapy Market Segmental Analysis

Global Home Infusion Therapy Market is segmented by Product, Application, Administration and Region. Based on Product, the market is segmented into Infusion Pumps (Elastomeric, Electromechanical, Gravity, Others), Intravenous Sets, IV Cannulas, Needleless Connectors. Based on Application, the market is segmented into Anti Infective, Endocrinology (Diabetes, Others), Hydration Therapy (Athletes, Others), Chemotherapy, Enteral Nutrition, Parental Nutrition, Specialty Pharmaceuticals, Others. Based on Administration, the market is segmented into Intramuscular, Subcutaneously, Epidural. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Home Infusion Therapy Market

One of the primary factors fueling the growth of the global home infusion therapy market is the escalating incidence of chronic illnesses, including diabetes, cancer, and cardiovascular diseases. As more individuals require ongoing medical attention and treatment, home infusion therapy emerges as a convenient and effective solution. This method not only minimizes the need for hospital visits but also enhances patient comfort, making it an appealing option for both healthcare providers and patients. The demand for effective management of chronic conditions is expected to further boost the market, highlighting the importance of home infusion services in contemporary healthcare practices.

Restraints in the Global Home Infusion Therapy Market

One significant constraint hindering the expansion of the global home infusion therapy market is the insufficient awareness and training among both healthcare professionals and patients. Many patients lack a clear understanding of home infusion therapy, leading to underutilization of these services. On the other hand, healthcare providers often do not receive adequate training in managing infusion therapies or guiding patients through pre-treatment processes. This knowledge gap not only affects the quality of care provided but also limits patient acceptance and adoption of home infusion therapy, ultimately impacting the overall growth prospects and market share of this vital healthcare sector.

Market Trends of the Global Home Infusion Therapy Market

The global home infusion therapy market is witnessing a significant shift towards patient-centric care, reflecting a growing preference for personalized treatment plans that prioritize individual patient needs. This trend is driven by the increasing demand for convenience and comfort, allowing patients to manage chronic conditions from the comfort of their homes while reducing hospital visits and associated healthcare costs. advancements in infusion technologies, enhanced caregiver training, and improved patient education are further fueling this trend, making home infusion a viable alternative to traditional hospital-based care. As a result, the market is poised for robust growth, catering to a more empowered and involved patient population.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Patent Analysis

Home Infusion Therapy Market Size by Product & CAGR (2024-2031)

Market Overview
Infusion Pumps
- Elastomeric
- Electromechanical
- Gravity
- Others
Intravenous Sets
IV Cannulas
Needleless Connectors

Home Infusion Therapy Market Size by Application & CAGR (2024-2031)

Market Overview
Anti Infective
Endocrinology
- Diabetes
- Others
Hydration Therapy
- Athletes
- Others
Chemotherapy
Enteral Nutrition
Parental Nutrition
Specialty Pharmaceuticals
Others

Home Infusion Therapy Market Size by Administration & CAGR (2024-2031)

Market Overview
Intramuscular
Subcutaneously
Epidural

Home Infusion Therapy Market Size & CAGR (2024-2031)

North America (Product, Application, Administration)
- US
- Canada
Europe (Product, Application, Administration)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product, Application, Administration)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product, Application, Administration)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, Administration)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Option Care Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AmerisourceBergen Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CVS Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Walgreens Boots Alliance (USA/UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Linde plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Centene Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
UnitedHealth Group (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anthem, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Humana Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cigna Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICU Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendation